STAND. COM. REP. NO. 3724

 

Honolulu, Hawaii

 

RE: GOV. MSG. NO. 629

 

 

 

Honorable Ronald D. Kouchi

President of the Senate

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

 

Sir:

 

Your Committee on Commerce, Consumer Protection, and Health, to which was referred Governor's Message No. 629, submitting for study and consideration the nomination of:

 

Board of Pharmacy

 

G.M. No. 629

JULIE TAKISHIMA-LACASA,

for a term to expire 06-30-2022,

 

begs leave to report as follows:

 

Your Committee reviewed the personal history, resume, and statement submitted by Julie Takishima-Lacasa for service on the Board of Pharmacy.

 

Your Committee received testimony in support of the nomination for the reappointment of Julie Takishima-Lacasa from the Department of Commerce and Consumer Affairs and three individuals.

 

Upon review of the testimony, your Committee finds that Dr. Takishima-Lacasa's background, experience, and proven leadership on the Board of Pharmacy qualify her to be nominated for reappointment to the Board of Pharmacy as a public member. Your Committee notes that Dr. Takishima-Lacasa is a clinical psychologist at Manakai O Mālama, an integrative multidisciplinary health clinic, and has extensive experience serving rural, underserved communities across the State, which has enabled her to bring a unique public member perspective to the Board of Pharmacy. Dr. Takishima-Lacasa is also a researcher at the University of Hawaii at Mānoa's Social Science Research Institute and is extremely active in her community and with her professional organizations, the American Psychological Association and Hawaii Psychological Association. Your Committee further finds that Dr. Takishima-Lacasa has been a member of the Board of Pharmacy since 2016, currently serves as the Board's vice chair, and her professional and personal commitment to addressing and advocating for the needs of underserved communities in the State continues to be an asset to the Board. Your Committee therefore recommends that Dr. Takishima-Lacasa be reappointed to the Board of Pharmacy based on her knowledge, background, and commitment to serving the community.

 

As affirmed by the record of votes of the members of your Committee on Commerce, Consumer Protection, and Health that is attached to this report, your Committee, after full consideration of the background, experience, and qualifications of the nominee, has found the nominee to be qualified for the position to which nominated and recommends that the Senate advise and consent to the nomination.

 

Respectfully submitted on behalf of the members of the Committee on Commerce, Consumer Protection, and Health,

 

 

 

____________________________

ROSALYN H. BAKER, Chair